Evidence map›Paper›PMID 34841710›Full record

ArticleClinical and translational medicine2021

Analytics of the clinical implementation of pharmacogenomics testing in 12 758 individuals.

Yang Wang, Fan Xiao, Yan Chen, Le-Dong Xiao, Lei-Yun Wang, Yan Zhan, Xing-Liang Xiong, Gang Zhou, Rong Liu, Dong-Sheng Ouyang and 7 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. The history and future of pharmacogenetics in Aotearoa/New Zealand.Journal of the Royal Society of New Zealand · 2025
    Review
  3. Article
  4. The Implementation of Pharmacogenetics in the United Kingdom.Handbook of experimental pharmacology · 2023
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Yang WangDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P. R. China.
Fan XiaoDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P. R. China.
Yan ChenDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P. R. China.
Le-Dong XiaoDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P. R. China.
Lei-Yun WangDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P. R. China.
Yan ZhanDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P. R. China.
Xing-Liang XiongDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P. R. China.
Gang ZhouDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P. R. China.
Rong LiuDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P. R. China.
Dong-Sheng OuyangDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P. R. China.
Zhi LiDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P. R. China.
Howard L McLeodDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P. R. China.ORCID 0000-0002-9004-9232
Wei ZhangDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P. R. China.
Qing LiDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P. R. China.
Zhao-Qian LiuDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P. R. China.
Hong-Hao ZhouDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P. R. China.
Ji-Ye YinDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P. R. China.ORCID 0000-0002-1244-5045

Funding

Hunan Cancer Hospital Climb Plan YF2020011the National Natural Science Foundation of China 81773823the National Natural Science Foundation of China 82073943the National Science and Technology Major Project of China 2017ZX09304014
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ChinaClopidogrelCytochrome P-450 CYP2C19Cytochrome P-450 CYP2C9HumansPharmacogenomic TestingPrecision MedicineVitamin K Epoxide ReductasesWarfarinClopidogrelCYP2C19 protein, humanCYP2C9 protein, humanCytochrome P-450 CYP2C19Cytochrome P-450 CYP2C9Vitamin K Epoxide ReductasesVKORC1 protein, humanWarfarin

Identifiers

PMID34841710
PMCPMC8571952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.